$5.10 0.04 (+0.69%)
2/13/2012 10:13 AM

SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)

CAPS Rating: 4 out of 5

A biopharmaceutical company, which is engaged in the development and commercialization of novel therapeutics to treat life-threatening diseases.

Featured Broker Partners


Advertisement